跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VENLAFAXINE XR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VENLAFAXINE XR
Authorized
STANDARD
VENLAFAXINE XR
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
86f4c23bb747adb3
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
86f4c23bb747adb3
Drug Approval Canada Name
VENLAFAXINE XR
Product Name
VENLAFAXINE XR
Status
Marketed
Status Date
2021-12-29
Original Market Date
2021-12-29
Din
02516535
Drug Class
Human
Dosage Form
Capsule (Extended Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX16 VENLAFAXINE
Atc Name
n 06 ax 16
Aig Number
0131294002
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE)
37.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
86f4c23bb747adb3
Type
Standard
Back to Health Canada Approvals